SAVANNAH WETZLER: Open Payments
NPI 1851713275 · MEXIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 33 payments from 11 companies in 2025. Trend: 2023 $657 · 2024 $489 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $184 |
| Lilly USA, LLC | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Novo Nordisk Inc | 3 | $47 |
| Amgen Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 7 | $34 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, Kerendia, Ozempic, UBRELVY, EVENITY, JARDIANCE, REXULTI, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
